Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands
Tessa van der Maaden, Elizabeth N. Mutubuki, Siméon de Bruijn, Ka Yin Leung, Hans Knoop, Jaap Slootweg, Anna D. Tulen, Albert Wong, Albert Jan van Hoek, Eelco Franz, Cees C. Van den Wijngaard
doi: https://doi.org/10.1101/2022.06.15.22276439
Tessa van der Maaden
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Elizabeth N. Mutubuki
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Siméon de Bruijn
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Ka Yin Leung
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Hans Knoop
3Department of Medical Psychology and Amsterdam Public Health from the Amsterdam UMC, location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands
Jaap Slootweg
2Centre for Sustainability, Environment and Health, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands
Anna D. Tulen
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Albert Wong
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Albert Jan van Hoek
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Eelco Franz
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Cees C. Van den Wijngaard
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted June 16, 2022.
Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands
Tessa van der Maaden, Elizabeth N. Mutubuki, Siméon de Bruijn, Ka Yin Leung, Hans Knoop, Jaap Slootweg, Anna D. Tulen, Albert Wong, Albert Jan van Hoek, Eelco Franz, Cees C. Van den Wijngaard
medRxiv 2022.06.15.22276439; doi: https://doi.org/10.1101/2022.06.15.22276439
Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands
Tessa van der Maaden, Elizabeth N. Mutubuki, Siméon de Bruijn, Ka Yin Leung, Hans Knoop, Jaap Slootweg, Anna D. Tulen, Albert Wong, Albert Jan van Hoek, Eelco Franz, Cees C. Van den Wijngaard
medRxiv 2022.06.15.22276439; doi: https://doi.org/10.1101/2022.06.15.22276439
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2317)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11650)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3654)
- Geriatric Medicine (343)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3406)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6046)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)